Catalyst

Slingshot members are tracking this event:

Marinus (MRNS) to Commence Phase 2 Study Evaluating Ganaxolone IV in Life-Threatening Epilepsy in H1 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MRNS

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 01, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2, Initiation, Ganaxolone Iv, Life-threatening, Epilepsy, Refractory Status Epilepticus (rse)